Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 27;829(1-2):75-81. doi: 10.1016/j.jchromb.2005.09.034. Epub 2005 Oct 24.

Abstract

A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) method has been developed and validated for simultaneous quantification of venlafaxine (VEN) and O-desmethyl venlafaxine (ODV) in human plasma. The analytes were extracted from human plasma by using solid-phase extraction (SPE) technique. Escitalopram (ESC) was used as the internal standard. A Betasil C18 column provided chromatographic separation of analytes followed by detection with mass spectrometry. The mass transition ion-pair has been followed as m/z 278.27-->121.11 for VEN, m/z 264.28-->107.10 for ODV and m/z 325.00-->262.00 for ESC. The method involves a solid phase extraction from plasma, simple isocratic chromatography conditions and mass spectrometric detection that enables detection at nanogram levels. The proposed method has been validated with linear range of 3-300 ng/ml for VEN and 6-600 ng/ml for ODV. The intrarun and interrun precision and accuracy values are within 10%. The overall recoveries for VEN and ODV were 95.9 and 81.7%, respectively. Total elution time as low as 3 min only.

Publication types

  • Validation Study

MeSH terms

  • Antidepressive Agents, Second-Generation / blood*
  • Chromatography, Liquid / methods*
  • Citalopram / blood
  • Cyclohexanols / blood*
  • Desvenlafaxine Succinate
  • Humans
  • Reference Standards
  • Spectrometry, Mass, Electrospray Ionization / methods*
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Citalopram
  • Venlafaxine Hydrochloride
  • Desvenlafaxine Succinate